GLP-1 receptor agonists and the risk of thyroid cancer

被引：0
|
作者：
Gouverneur, A. [1 ]
Penichon, M. [2 ]
Bezin, J. [1 ]
Garrel, R. [3 ]
Hillaire-Buys, D. [4 ]
Pariente, A. [1 ]
Faillie, J. L. [5 ]
机构：
[1] Univ Bordeaux, CHU Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM,Pharmacoepidemiol Team,Serv Pharmacol,Pole, Bordeaux, France
[2] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, Pharmacoepidemiol Team, Bordeaux, France
[3] CHU Montpellier, Serv Chirurg ORL, Montpellier, France
[4] CHU Montpellier, Dept Pharmacol Med & Toxicol, Montpellier, France
[5] Univ Montpellier, CHU Montpellier, Inst Desbrest Epidemiol & Sante Publ, Dept Pharmacol Med & Toxicol,INSERM, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-026
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [31] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [32] GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation
    Madsen, Lars Wichmann
    Knauf, Jeffrey A.
    Gotfredsen, Carsten
    Pilling, Andrew
    Sjogren, Ingrid
    Andersen, Soren
    Andersen, Lene
    de Boer, Anne Sietske
    Manova, Katia
    Barlas, Afsar
    Vundavalli, Sushil
    Nyborg, Niels C. Berg
    Knudsen, Lotte Bjerre
    Moelck, Anne Marie
    Fagin, James A.
    ENDOCRINOLOGY, 2012, 153 (03) : 1538 - 1547
  • [33] Should GLP-1 receptor agonists be used with caution in high risk population for colorectal cancer?
    Sun, Yang
    Fan, Lei
    Meng, Jin
    Zhang, Feng
    Zhang, Dian
    Mei, Qibing
    MEDICAL HYPOTHESES, 2014, 82 (03) : 255 - 256
  • [34] Exploring the potential impact of GLP-1 receptor agonists in cancer therapy
    Aslam, Baseer
    Bin Zafar, Muhammad D.
    Changez, Mah I. Khan
    Abdullah, Muhammad
    Safwan, Muhammad
    Qamar, Bisma
    Shinwari, Abdullah
    Rai, Sanjana
    MINERVA ENDOCRINOLOGY, 2023,
  • [35] Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
    Liu, Qiyuan Keith
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [36] The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
    Silvia Tempia Valenta
    Alba Nicastri
    Federica Perazza
    Federica Marcolini
    Valentina Beghelli
    Anna Rita Atti
    Maria Letizia Petroni
    Current Treatment Options in Psychiatry, 2024, 11 (4) : 310 - 357
  • [37] GLP-1 receptor agonists in metformin therapy: risk of GI side effects?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 93 - 94
  • [38] The Neuroprotection by GLP-1 Receptor Agonists in High Cardiovascular risk and Neurodegenerative Diseases
    Mena, D.
    Alves, I. N.
    Silva, D. F.
    Candeias, E.
    Oliveira, C. R.
    Seica, R.
    Monteiro, P. F.
    Moreira, P. I.
    Duarte, A. I.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 49 - 49
  • [39] GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
    Rizzo, Manfredi
    Nikolic, Dragana
    Patti, Angelo Maria
    Mannina, Carlo
    Montalto, Giuseppe
    McAdams, Brooke S.
    Rizvi, Ali A.
    Cosentino, Francesco
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (09): : 2814 - 2821
  • [40] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
12345